What were the pros and cons of Sangamo pursuing its gene editing programs alone versus working with a partner? Does the HIV program offer any special opportunities or challenges? What do you think Sangamo should do regarding the HIV program? Should it license the technology to a large pharmaceutical? Should it form a joint venture […]
Tag Archives: Sangamo
